I'm here at the American Society of Hematology (ASH) meetings in Orlando, helping CrowdCare Foundation founder, Jenny Ahlstrom. The big news here today focused on an impressive breakthrough in T cell therapy. I wrote about it earlier for Jenny's MyelomaCrowd.org site: CAR T cell breakthrough announced at ASH Exciting new therapy news from the American
Tuesday night I was part of a panel that questioned myeloma T cell therapy pioneer, Dr. Ivan Borrello of Johns Hopkins in Baltimore. The hour shed light on how and why researchers are so hopeful about the potential of T cell immunotherapy. Here is the replay link to the broadcast, courtesy of Cure Talks: http://www.curetalks.com/event/rsvp/A-Novel-More-Precise-and-Effective-T-Cell-Immunoth/243/
What did I do while I was stuck in Iowa waiting for test results and harvesting my stem cells? I updated two of my books, New Myeloma Therapies from a Patient's Perspective, and Financial Aid for Myeloma Patients and Caregivers. The New Therapies book has shipped and is ready for sale. I don't make much
Researchers at the University of Pennsylvania continue to make progress modifying a patient's own T cells to attack their myeloma. News of early success broke at ASCO this summer: CTL019 Trial results at ASCO beyond impressive! Posted on June 18 2015 by Pat Killingsworth | 1,279 views Medical Xpress ran an article about it Wednesday.